Envoy Medical, Inc. (COCH) Executive Compensation
Envoy Medical, Inc. (COCH) is a publicly traded company on the Nasdaq, categorized under SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: COCH
CIK: 1840877
Exchange: Nasdaq
SIC 3842: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Grant Thornton LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerAngela Garcia-Lopez
Audit LocationFt. Lauderdale, Florida, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-16 | 2026-10-12 | CURRENT REPORT | 0001213900-26-110266 | View SEC Doc Filr Page |
| 8-K | 2026-10-07 | 2026-10-06 | CURRENT REPORT | 0001213900-26-107434 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-09-14 | — | SCHEDULE 13G/A Filing | 0001094891-26-000284 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-02 | — | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-096772 | View SEC Doc Filr Page |
| DEF 14A | 2026-08-31 | 2026-10-12 | PROXY STATEMENT | 0001213900-26-095756 | View SEC Doc Filr Page |
| 8-K | 2026-08-27 | 2026-08-24 | CURRENT REPORT | 0001213900-26-094447 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-24 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0000914190-26-000137 | View SEC Doc Filr Page |
| PRE 14A | 2026-08-19 | 2026-08-19 | PROXY STATEMENT | 0001213900-26-091704 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | CURRENT REPORT | 0001213900-26-087221 | View SEC Doc Filr Page |
| 10-Q | 2026-08-10 | 2026-06-30 | QUARTERLY REPORT | 0001213900-26-086974 | View SEC Doc Filr Page |
| 8-K | 2026-06-30 | 2026-06-24 | CURRENT REPORT | 0001213900-26-073659 | View SEC Doc Filr Page |
| 8-K | 2026-06-25 | 2026-06-19 | CURRENT REPORT | 0001213900-26-072033 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-19 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0000914190-26-000100 | View SEC Doc Filr Page |
| EFFECT | 2026-06-16 | — | EFFECT Filing | 9999999995-26-002008 | View SEC Doc Filr Page |
| POS AM | 2026-06-12 | — | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 | 0001213900-26-068309 | View SEC Doc Filr Page |
| S-8 | 2026-06-12 | — | REGISTRATION STATEMENT | 0001213900-26-068305 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-05-29 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0000914190-26-000095 | View SEC Doc Filr Page |
| 8-K | 2026-05-22 | 2026-05-19 | CURRENT REPORT | 0001213900-26-060556 | View SEC Doc Filr Page |
| 8-K | 2026-05-18 | 2026-05-12 | CURRENT REPORT | 0001213900-26-058429 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001104659-26-062703 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-14 | — | SCHEDULE 13G Filing | 0001171520-26-000099 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-11 | — | SCHEDULE 13G/A Filing | 0001493152-26-022322 | View SEC Doc Filr Page |
| 10-Q | 2026-05-11 | 2026-03-31 | QUARTERLY REPORT | 0001213900-26-054209 | View SEC Doc Filr Page |
| 8-K | 2026-05-11 | 2026-05-11 | CURRENT REPORT | 0001213900-26-054185 | View SEC Doc Filr Page |
| 8-K | 2026-04-21 | 2026-04-15 | CURRENT REPORT | 0001213900-26-046197 | View SEC Doc Filr Page |